If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Exova opens Pittsburgh laboratory

13 Oct 2015 14:00

RNS Number : 0736C
Exova Group PLC
13 October 2015
 

 

 

13 October 2015

 

Exova opens Pittsburgh laboratory

 

Exova, the global testing group, has opened its first facility in the North East of the US with a new materials and corrosion testing laboratory in Pittsburgh.

 

The laboratory will provide testing and consultancy services in metallurgy, polymers and coatings as well as corrosion risk assessment and mitigation, primarily to the oil & gas and industrials sectors.

The location of the laboratory close to the Marcellus shale field brings Exova's services to an important region by providing particular expertise in supporting field inspection and corrosion mitigation.

 

The laboratory also extends the company's advisory services in areas including failure analysis and risk assessment. Combining with Exova's existing global capabilities, the specialist team in Pittsburgh will work with customers to improve the performance and quality to their in-service assets.

 

The new facility, under the operational leadership of General Manager, John Ciliege, and technical leadership of Dr Mehrooz Zamanzadeh, will be part of Exova's oil and gas division in the US and will also work closely with the company's network of oil & gas, aerospace and industrials laboratories worldwide.

 

Gary Brimmage, President of Exova in the Americas comments: "This new investment underlines our commitment to being at the forefront of industrial materials and corrosion solutions. Offering both testing and advisory capabilities we are able to support our customers throughout the entire life cycle of oil and gas and industrial assets, helping them to meet their technical and commercial needs."

 

The Pittsburgh laboratory represents Exova's 143rd facility in 32 countries worldwide.

 

 

 

 

All media enquiries, please contact:

 

Stuart Neill, Group Communications Manager, Exova

Tel. +44 131 335 4371 / +44 7799 365 043

E: stuart.neill@exova.com

 

Angela Casey

Pagoda Porter Novelli

T: +44 131 556 0770

E: angela.casey@pagodapr.com

 

Ian Middleton or Samantha Trillwood

Powerscourt

T: +44 (0)20 7250 1446

E: exova@powerscourt-group.com

 

Exova

 

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 143 laboratories and offices in 32 countries and employs around 4,500 people throughout Europe, the Americas, the Middle East and Asia/Asia Pacific.

 

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors from health sciences to aerospace, transportation, oil and gas, fire and construction.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGGAUUUPAUBW
Date   Source Headline
15th Feb 20169:00 amRNSExova acquires majority stake in Admaterials
10th Feb 20164:35 pmRNSPrice Monitoring Extension
15th Jan 20167:00 amRNSTrading Statement
31st Dec 201512:35 pmRNSPrice Monitoring Extension
31st Dec 20159:00 amRNSNotification of Transactions of Directors & PDMRs
18th Dec 201512:16 pmRNSAppointment of Senior Independent Director
9th Dec 20153:18 pmRNSChange of financial results date
8th Dec 201510:35 amRNSDirector/PDMR Shareholding
30th Nov 20157:00 amRNSAppointment of Chief Financial Officer
11th Nov 20157:00 amRNSTrading Statement
4th Nov 201510:30 amRNSExova appoints Paul Barry as MD for Europe
3rd Nov 201511:14 amRNSNotification of transactions of Directors & PDMRs
21st Oct 20159:18 amRNSDirector/PDMR Shareholding
19th Oct 201511:51 amRNSDirector/PDMR Shareholding
13th Oct 20152:00 pmRNSExova opens Pittsburgh laboratory
5th Oct 201510:00 amRNSExova wins Qatar testing contract
2nd Oct 20159:04 amRNSNotification of transactions of Directors & PDMRs
1st Oct 201510:00 amRNSExova appoints managing director for MEAAP region
28th Sep 20157:00 amRNSAppointment of Chief Financial Officer
10th Sep 201510:23 amRNSDirector/PDMR Shareholding
8th Sep 201510:50 amRNSDirector Declaration
7th Sep 20159:30 amRNSDirector/PDMR Shareholding
1st Sep 201510:57 amRNSExova wins UAE outsourcing deal
28th Aug 20157:01 amRNSDirectorate Change
28th Aug 20157:00 amRNSHalf Yearly Report
6th Aug 20159:11 amRNSTR-1: Notification of Major Interest in Shares
29th Jul 201511:00 amRNSExova wins long term agreement
22nd Jul 201510:00 amRNSExova opens new Malaysia lab
7th Jul 201510:00 amRNSExova extends relationship with Maersk Oil
2nd Jul 20154:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20154:35 pmRNSPrice Monitoring Extension
24th Jun 20151:40 pmRNSDirector/PDMR Shareholding
23rd Jun 20151:33 pmRNSDirector/PDMR Shareholding
17th Jun 20152:50 pmRNSDirector/PDMR Shareholding
9th Jun 201511:00 amRNSExova lands Kaombo Project contract
8th Jun 20152:10 pmRNSDirector/PDMR Shareholding
19th May 201512:20 pmRNSDirector/PDMR Shareholding
14th May 20154:52 pmRNSResult of AGM
14th May 20157:00 amRNSTrading Statement
20th Apr 201512:50 pmRNSExova wins contract with AGDC
20th Apr 20157:00 amRNSChange of Adviser
10th Apr 20159:46 amRNSAnnual Financial Report
16th Mar 20153:05 pmRNSDirector/PDMR Shareholding
4th Mar 20157:00 amRNSFinal Results
24th Feb 201512:55 pmRNSTR-1: Notification of Major Interest in Shares
23rd Feb 20159:00 amRNSExova wins long term agreement with Böhler
9th Feb 201510:00 amRNSExova acquires Environmental Evaluation
4th Feb 201510:30 amRNSExova agrees calibration outsourcing deal
2nd Feb 20157:00 amRNSExova contract wins for testing on Doha Metro
22nd Jan 20159:20 amRNSNotification of New Directorship

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.